Works matching IS 03065251 AND DT 1976 AND VI 3 AND IP S2
1
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 391, doi. 10.1111/j.1365-2125.1976.tb03731.x
- Article
2
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 411, doi. 10.1111/j.1365-2125.1976.tb03735.x
- Article
3
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 375, doi. 10.1111/j.1365-2125.1976.tb03728.x
- Article
4
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 385, doi. 10.1111/j.1365-2125.1976.tb03730.x
- Scott, DB;
- Buckley, FP;
- Drummond, GB;
- Littlewoods, DG;
- Macrae, WR
- Article
5
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 405, doi. 10.1111/j.1365-2125.1976.tb03734.x
- Article
6
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 371, doi. 10.1111/j.1365-2125.1976.tb03727.x
- Article
7
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 401, doi. 10.1111/j.1365-2125.1976.tb03733.x
- Article
8
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 367, doi. 10.1111/j.1365-2125.1976.tb03726.x
- Article
9
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 395, doi. 10.1111/j.1365-2125.1976.tb03732.x
- Article
10
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 417, doi. 10.1111/j.1365-2125.1976.tb03736.x
- Article
11
- British Journal of Clinical Pharmacology, 1976, v. 3, n. S2, p. 381, doi. 10.1111/j.1365-2125.1976.tb03729.x
- Article